AAPL337.30+0.28 (+0.08%) ▲|ABBV264.08-1.00 (-0.38%) ▼|ABT101.64-1.85 (-1.79%) ▼|ACN179.52-4.00 (-2.18%) ▼|ADBE237.00-3.69 (-1.53%) ▼|AMAT469.82-4.56 (-0.96%) ▼|AMD620.99+6.38 (+1.04%) ▲|AMGN404.78-1.31 (-0.32%) ▼|AMT168.54-2.25 (-1.31%) ▼|AMZN248.82-0.45 (-0.18%) ▼|AVGO350.06-4.93 (-1.39%) ▼|AXP303.16+1.20 (+0.40%) ▲|BA196.84-3.09 (-1.55%) ▼|BAC55.93-0.07 (-0.13%) ▼|BKNG156.60+0.70 (+0.45%) ▲|BLK1,065.53+4.64 (+0.44%) ▲|BMY60.88-0.28 (-0.45%) ▼|BNY149.77+0.26 (+0.17%) ▲|BRK-B506.85-0.32 (-0.06%) ▼|C132.15+0.22 (+0.17%) ▲|CAT803.23-8.79 (-1.08%) ▼|CL85.75-0.19 (-0.22%) ▼|CMCSA22.21-0.34 (-1.51%) ▼|COF195.65-0.45 (-0.23%) ▼|COP130.03+1.94 (+1.51%) ▲|COST898.04-6.67 (-0.74%) ▼|CRM238.95+1.37 (+0.58%) ▲|CSCO105.66-0.77 (-0.72%) ▼|CVS84.83-1.03 (-1.20%) ▼|CVX207.13+1.62 (+0.79%) ▲|DE694.97-14.51 (-2.05%) ▼|DHR222.23+0.67 (+0.30%) ▲|DIS104.85+1.39 (+1.34%) ▲|DUK113.88-0.30 (-0.26%) ▼|EMR155.06+0.47 (+0.30%) ▲|FDX281.15-10.36 (-3.55%) ▼|GD340.21-3.12 (-0.91%) ▼|GE321.37+1.57 (+0.49%) ▲|GEV955.38+3.56 (+0.37%) ▲|GILD150.80-0.57 (-0.38%) ▼|GM81.60-2.18 (-2.60%) ▼|GOOG337.17+2.19 (+0.65%) ▲|GOOGL341.22+3.39 (+1.00%) ▲|GS921.45-14.92 (-1.59%) ▼|HD291.69-5.03 (-1.70%) ▼|HON211.92-0.65 (-0.31%) ▼|IBM228.01-4.76 (-2.04%) ▼|INTC125.29+2.69 (+2.19%) ▲|INTU278.49-8.32 (-2.90%) ▼|ISRG400.74+2.44 (+0.61%) ▲|JNJ271.31+2.14 (+0.80%) ▲|JPM336.84-0.69 (-0.20%) ▼|KO88.58+0.49 (+0.56%) ▲|LIN469.52-0.21 (-0.04%) ▼|LLY1,187.11+36.12 (+3.14%) ▲|LMT527.16+2.48 (+0.47%) ▲|LOW188.12-3.24 (-1.69%) ▼|LRCX303.29-3.99 (-1.30%) ▼|MA561.07+1.15 (+0.20%) ▲|MCD239.71+1.39 (+0.58%) ▲|MDLZ60.96-0.48 (-0.78%) ▼|MDT88.91-0.39 (-0.44%) ▼|META770.02+25.92 (+3.48%) ▲|MMM168.59-1.71 (-1.00%) ▼|MO69.18+0.23 (+0.33%) ▲|MRK148.17+0.09 (+0.06%) ▲|MS196.31-2.08 (-1.05%) ▼|MSFT495.23-5.36 (-1.07%) ▼|MU1,070.16-1.72 (-0.16%) ▼|NEE76.23-0.79 (-1.03%) ▼|NFLX71.69+0.33 (+0.46%) ▲|NKE35.73-0.32 (-0.89%) ▼|NOW138.61-2.17 (-1.54%) ▼|NVDA224.22-1.29 (-0.57%) ▼|ORCL138.71-5.85 (-4.05%) ▼|PEP129.11-1.08 (-0.83%) ▼|PFE28.47+0.29 (+1.01%) ▲|PG146.89-0.50 (-0.34%) ▼|PLTR192.62+0.83 (+0.43%) ▲|PM191.41+0.57 (+0.30%) ▲|QCOM193.73-3.52 (-1.78%) ▼|RTX191.22-0.98 (-0.51%) ▼|SBUX93.16-0.98 (-1.04%) ▼|SCHW99.28-0.22 (-0.22%) ▼|SO83.28-0.19 (-0.23%) ▼|SPG205.13+0.97 (+0.48%) ▲|T25.60+0.30 (+1.17%) ▲|TMO672.36+7.06 (+1.06%) ▲|TMUS165.37-0.29 (-0.18%) ▼|TSLA380.80+0.68 (+0.18%) ▲|TXN270.38-2.24 (-0.82%) ▼|UBER69.11-0.31 (-0.45%) ▼|UNH372.63+1.34 (+0.36%) ▲|UNP273.57-1.96 (-0.71%) ▼|UPS92.32-3.50 (-3.65%) ▼|USB58.33-0.16 (-0.27%) ▼|V366.09+4.57 (+1.26%) ▲|VZ47.48+0.96 (+2.06%) ▲|WFC81.73-0.17 (-0.21%) ▼|WMT108.54-1.99 (-1.80%) ▼|XOM162.43+1.20 (+0.74%) ▲|AAPL337.30+0.28 (+0.08%) ▲|ABBV264.08-1.00 (-0.38%) ▼|ABT101.64-1.85 (-1.79%) ▼|ACN179.52-4.00 (-2.18%) ▼|ADBE237.00-3.69 (-1.53%) ▼|AMAT469.82-4.56 (-0.96%) ▼|AMD620.99+6.38 (+1.04%) ▲|AMGN404.78-1.31 (-0.32%) ▼|AMT168.54-2.25 (-1.31%) ▼|AMZN248.82-0.45 (-0.18%) ▼|AVGO350.06-4.93 (-1.39%) ▼|AXP303.16+1.20 (+0.40%) ▲|BA196.84-3.09 (-1.55%) ▼|BAC55.93-0.07 (-0.13%) ▼|BKNG156.60+0.70 (+0.45%) ▲|BLK1,065.53+4.64 (+0.44%) ▲|BMY60.88-0.28 (-0.45%) ▼|BNY149.77+0.26 (+0.17%) ▲|BRK-B506.85-0.32 (-0.06%) ▼|C132.15+0.22 (+0.17%) ▲|CAT803.23-8.79 (-1.08%) ▼|CL85.75-0.19 (-0.22%) ▼|CMCSA22.21-0.34 (-1.51%) ▼|COF195.65-0.45 (-0.23%) ▼|COP130.03+1.94 (+1.51%) ▲|COST898.04-6.67 (-0.74%) ▼|CRM238.95+1.37 (+0.58%) ▲|CSCO105.66-0.77 (-0.72%) ▼|CVS84.83-1.03 (-1.20%) ▼|CVX207.13+1.62 (+0.79%) ▲|DE694.97-14.51 (-2.05%) ▼|DHR222.23+0.67 (+0.30%) ▲|DIS104.85+1.39 (+1.34%) ▲|DUK113.88-0.30 (-0.26%) ▼|EMR155.06+0.47 (+0.30%) ▲|FDX281.15-10.36 (-3.55%) ▼|GD340.21-3.12 (-0.91%) ▼|GE321.37+1.57 (+0.49%) ▲|GEV955.38+3.56 (+0.37%) ▲|GILD150.80-0.57 (-0.38%) ▼|GM81.60-2.18 (-2.60%) ▼|GOOG337.17+2.19 (+0.65%) ▲|GOOGL341.22+3.39 (+1.00%) ▲|GS921.45-14.92 (-1.59%) ▼|HD291.69-5.03 (-1.70%) ▼|HON211.92-0.65 (-0.31%) ▼|IBM228.01-4.76 (-2.04%) ▼|INTC125.29+2.69 (+2.19%) ▲|INTU278.49-8.32 (-2.90%) ▼|ISRG400.74+2.44 (+0.61%) ▲|JNJ271.31+2.14 (+0.80%) ▲|JPM336.84-0.69 (-0.20%) ▼|KO88.58+0.49 (+0.56%) ▲|LIN469.52-0.21 (-0.04%) ▼|LLY1,187.11+36.12 (+3.14%) ▲|LMT527.16+2.48 (+0.47%) ▲|LOW188.12-3.24 (-1.69%) ▼|LRCX303.29-3.99 (-1.30%) ▼|MA561.07+1.15 (+0.20%) ▲|MCD239.71+1.39 (+0.58%) ▲|MDLZ60.96-0.48 (-0.78%) ▼|MDT88.91-0.39 (-0.44%) ▼|META770.02+25.92 (+3.48%) ▲|MMM168.59-1.71 (-1.00%) ▼|MO69.18+0.23 (+0.33%) ▲|MRK148.17+0.09 (+0.06%) ▲|MS196.31-2.08 (-1.05%) ▼|MSFT495.23-5.36 (-1.07%) ▼|MU1,070.16-1.72 (-0.16%) ▼|NEE76.23-0.79 (-1.03%) ▼|NFLX71.69+0.33 (+0.46%) ▲|NKE35.73-0.32 (-0.89%) ▼|NOW138.61-2.17 (-1.54%) ▼|NVDA224.22-1.29 (-0.57%) ▼|ORCL138.71-5.85 (-4.05%) ▼|PEP129.11-1.08 (-0.83%) ▼|PFE28.47+0.29 (+1.01%) ▲|PG146.89-0.50 (-0.34%) ▼|PLTR192.62+0.83 (+0.43%) ▲|PM191.41+0.57 (+0.30%) ▲|QCOM193.73-3.52 (-1.78%) ▼|RTX191.22-0.98 (-0.51%) ▼|SBUX93.16-0.98 (-1.04%) ▼|SCHW99.28-0.22 (-0.22%) ▼|SO83.28-0.19 (-0.23%) ▼|SPG205.13+0.97 (+0.48%) ▲|T25.60+0.30 (+1.17%) ▲|TMO672.36+7.06 (+1.06%) ▲|TMUS165.37-0.29 (-0.18%) ▼|TSLA380.80+0.68 (+0.18%) ▲|TXN270.38-2.24 (-0.82%) ▼|UBER69.11-0.31 (-0.45%) ▼|UNH372.63+1.34 (+0.36%) ▲|UNP273.57-1.96 (-0.71%) ▼|UPS92.32-3.50 (-3.65%) ▼|USB58.33-0.16 (-0.27%) ▼|V366.09+4.57 (+1.26%) ▲|VZ47.48+0.96 (+2.06%) ▲|WFC81.73-0.17 (-0.21%) ▼|WMT108.54-1.99 (-1.80%) ▼|XOM162.43+1.20 (+0.74%) ▲|
18.7 C
New York
Thursday, September 24, 2026

Tag: FOR

newssourceFORcompanyinformationcontent1releasesmarket

Johnson & Johnson presents new IMAAVY®▼ (nipocalimab) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalised myasthenia gravis

BEERSE, BELGIUM, June 26, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced new data across 12 abstracts at the European Academy of Neurology (EAN) 2026 Congress that offer additional insight into the use of IMAAVY®▼(nipocalimab) throughout clinically relevant points in the generalised myasthenia gravis (gMG) treatment journey. The analyses include adults with anti-AChRa or anti-MuSKb antibody-positive gMG who were early in their disease course or had lower baseline symptom burden – providing insight into the potential importance of addressing pathogenic immunoglobulin G (IgG) early in disease progression where use of advanced therapies may be less common.1,2 Additional research to be shared include outcomes shortly after common infections, which are a known cause of disease exacerbations in gMG, and plans to address evidence gaps in the use of nipocalimab during pregnancy.3,4

From Cryptocurrency to Stocks: BulkQuant Expands AI Trading Robot Platform to Help Retail Investors Explore Automated Trading Strategies

London, United Kingdom, June 26, 2026 (GLOBE NEWSWIRE) --

BulkQuant, a fully managed AI trading robot platform, is expanding its automated trading ecosystem to help retail investors explore structured trading strategies across cryptocurrency, forex, and stock market environments.

University of Phoenix Launches Three New Artificial Intelligence Professional Development Pathways

New offerings help employees, senior leaders and healthcare professionals build practical AI skills for workplace application, governance and healthcare settingsPHOENIX, June 26, 2026 /PRNewswire/...

FEDERAL-PROVINCIAL-TERRITORIAL MEETING – Ministers Responsible for Canadian Francophonie Review Progress and Future Prospects

WINNIPEG, MB, June 26, 2026 /CNW/ - Under the theme Let's Celebrate the Francophonie at the Heart of Canada, the Ministers' Council on the Canadian Francophonie...

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

New analyses from the Phase 3 Vivacity-MG3 study support the impact of IMAAVY in anti-AChR+a, anti-MuSK+b adult patients with generalized myasthenia gravis (gMG) including...

PCS Edventures! Announces Results for Fiscal Year 2026

MERIDIAN, Idaho, June 26, 2026 (GLOBE NEWSWIRE) -- PCS Edventures!, Inc. (“PCSV”), a leading provider of TK-12 Science, Technology, Engineering and Mathematics (“STEM”) education programs, today announced results of operations for its fiscal year ended March 31, 2026.

Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar’s Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units

Cosmos Health signs distribution agreement with IMC, owner of Qatar's largest pharmacy chain. Secures purchase order of 31,000 Sky Premium Life units.

Canacol Energy Secures Key Restructuring Decision from Alberta Court; Colombian Consumer Protections Preserved

CALGARY, Alberta and BOGOTÁ, Colombia, June 26, 2026 (GLOBE NEWSWIRE) -- Canacol Energy Ltd. ("Canacol" or the "Company") (TSX: CNE), a leading natural gas exploration and production company operating in Colombia, today announced that the Court of King's Bench of Alberta issued a decision on June 24, 2026, granting Canacol permission to disclaim natural gas supply and transportation contracts as part of its ongoing restructuring under the Companies' Creditors Arrangement Act (CCAA).

Segway and Whoosh Launch Free Ride Campaign Across Mexico During the 2026 Tournament World Cup to Support Urban Mobility

BEIJING, June 26, 2026 /PRNewswire/ -- Segway Commercial, a global leader in shared micromobility solutions, has partnered with leading shared mobility operator Whoosh to...

Free People to Host “Feels Like Free People: A Summer Social” in Philadelphia with Music, Food, and a Cookie Queens Screening

The July 11 event at Marine Parade Grounds will bring together food trucks, lawn games, a DJ set, and a family-friendly documentary screening, with...

Segway and Whoosh Launch Free Ride Campaign Across Mexico During the 2026 Tournament World Cup to Support Urban Mobility

BEIJING, June 27, 2026 /PRNewswire/ -- Segway Commercial, a global leader in shared micromobility solutions, has partnered with leading shared mobility operator Whoosh to...

Alitheon FeaturePrint® Named “Overall Authentication Solution of the Year” in 2026 AI Breakthrough Awards Program

Ninth Annual Program Honors the AI Innovators Shaping the Next Era of Global Innovation 
Ninth Annual Program Honors the AI Innovators Shaping the Next Era of Global Innovation

Marie Brizard Wine & Spirits Correction of inaccurate information appearing on several stock market information platforms regarding the distribution of a dividend

Charenton-le-Pont, 26 June 2026

EDF: EDF announces the signature of an agreement to sell EDF power solutions in the United States and Canada

EDF announces the signature of an agreement to sell EDF power solutions in the United States and Canada

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFOR

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers